Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-24

Clinical Trial Update: Vosoritide for Short Stature in Turner Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating vosoritide for short stature in Turner syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vosoritide (vosoritide)

Snippet

Sponsor: Roopa Kanakatti Shankar, MBBS, MS | Conditions: Turner Syndrome, Short Stature | Phase 2 | Status: RECRUITING